Assessing pharmaceutical and illicit drugs abuse in a university environment through wastewater analysis.

Monitoring the presence of illicit and pharmaceutical drugs in wastewater has emerged as a powerful tool for determining drug consumption patterns and trends within a specific population group. In this study, an analytical method has been developed to determine the presence of forty psychoactive substances, including stimulants, benzodiazepines, antidepressants, and opioids, in wastewater. The proposed approach combines in-situ wastewater single sampling, solid-phase extraction, and ultra-high performance liquid chromatography coupled with tandem mass spectrometry determination.

[Participation of occupational health in controlling the COVID-19 pandemic in the Valencia Autonomous Community.].

In the Valencia Autonomous Community, the fight against the pandemic, in the workplace, has been articulated around joint action between the occupational health services and the Valencian public health system, promoted and coordinated by Public Health. There was experience in similar activities, but a great effort has been required in external and internal coordination, in adapting activities and information systems. Occupational risk prevention services have played an important role in the epidemiological surveillance and control of COVID-19 in companies and are also participating in vaccination.

[Non work-related sickness absence in 2013 in a Spanish banking sector company].

Objectives: To describe the incidence and duration of episodes of non work-related temporary sickness absence (SA) between January and December of 2013, by diagnostic groups, in a banking sector company.

Methods: Cross-sectional study of 3.193 episodes of SA (≥ day), excluding work-related injuries and illnesses.

[Four year follow-up of a screening program for prostate cancer in workers].

Objectives: To analyze our four-year follow-up experience (2008-2011) with a prostate cancer screening program offered to employees of a banking company.

Methods: Data were obtained from the health examinations carried out by the bank's in-house occupational health service (with centers in Barcelona, Madrid and Valencia). PSA (prostate-specific antigen) blood levels were measured and cases with high levels (>4 ng/ml) were followed through diagnosis and treatment, including a telephone survey of confirmed cases.